San Luis Wealth Advisors LLC Recursion Pharmaceuticals, Inc. Transaction History
San Luis Wealth Advisors LLC
- $484 Million
- Q3 2024
A detailed history of San Luis Wealth Advisors LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, San Luis Wealth Advisors LLC holds 10,500 shares of RXRX stock, worth $72,555. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,500Holding current value
$72,555% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
286Shares Held
242MCall Options Held
1.3MPut Options Held
2.22M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$226 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$174 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$168 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$120 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$106 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.25B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...